4.7 Article

Reprogramming of human pancreatic exocrine cells to β-like cells

期刊

CELL DEATH AND DIFFERENTIATION
卷 22, 期 7, 页码 1117-1130

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2014.193

关键词

-

资金

  1. Research Foundation - Flanders (FWO)
  2. JDRF
  3. European Foundation for the Study of Diabetes (EFSD)
  4. European Union [LSHB-CT-2005-512145, HEALTH-F5-2009-241883]
  5. NIH [P30 DK063720]
  6. Leona M and Harry B Helmsley Charitable Trust [2012PG-T1D017]
  7. Iaccoca Family Foundation
  8. European Foundation for the Study of Diabetes [NN 2014_1] Funding Source: researchfish

向作者/读者索取更多资源

Rodent acinar cells exhibit a remarkable plasticity as they can transdifferentiate to duct-, hepatocyte- and islet beta-like cells. We evaluated whether exocrine cells from adult human pancreas can similarly respond to proendocrine stimuli. Exocrine cells from adult human pancreas were transduced directly with lentiviruses expressing activated MAPK (mitogen-activated protein kinase) and STAT3 (signal transducer and activator of transcription 3) and cultured as monolayers or as 3D structures. Expression of STAT3 and MAPK in human exocrine cells activated expression of the proendocrine factor neurogenin 3 in 50% to 80% of transduced exocrine cells. However, the number of insulin-positive cells increased only in the exocrine cells grown initially in suspension before 3D culture. Lineage tracing identified human acinar cells as the source of Ngn3- and insulin-expressing cells. Long-term engraftment into immunocompromised mice increased the efficiency of reprogramming to insulin-positive cells. Our data demonstrate that exocrine cells from human pancreas can be reprogrammed to transplantable insulin-producing cells that acquire functionality. Given the large number of exocrine cells in a donor pancreas, this approach presents a novel strategy to expand cell therapy in type 1 diabetes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据